IGF2BP3 and urinary bladder carcinoma: Collectively, our results suggest that IGF2BP3 is upregulated in bladder carcinoma, and its elevated expression is linked to unfavorable clinicopathological characteristics, implying its possible oncogenic function in bladder cancer.